Caring about bone-modifying agents (BMAs) in women with early-stage breast cancer | Zendy

Charles L. Shapiro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Caring about bone-modifying agents (BMAs) in women with early-stage breast cancer

Author(s) -

Charles L. Shapiro

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.03.210

Subject(s) - breast cancer , medicine , stage (stratigraphy) , oncology , cancer , bioinformatics , biology , paleontology

Icahn School of Medicine at Mt Sinai, New York, NY 10029, USA Correspondence to: Charles L. Shapiro. Icahn School of Medicine at Mt Sinai, New York, NY 10029, USA. Email: charles.shapiro@mssm.edu. Provenance: This is an invited article commissioned by the Editorial Office, Annals of Translational Medicine. Comment on: Coleman R, Finkelstein DM, Barrios C, et al. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 2020;21:60-72.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research